Patent Grant
7718407
The present invention concerns the fermentative production of vitamin K2 (menaquinone-7: MK-7), using a Bacillus microorganism.
The invention concerns a mutant of the microorganism Bacillus subtilis deposited under the Budapest Treaty, which is able to produce MK-7 in high amounts, under specific culture conditions.
Vitamin K is an essential cofactor for the formation of γ-carboxyglutamic acid (Gla) residues in proteins (Olson, R. E., 19841-Suttie, J. W., 19852). The Gla-containing proteins bind calcium ions and influence, for example, blood coagulation and tissue calcification (e.g., osteocalcin found in bone tissues) (Hauschka P. V. et al. 19783-Price, P. A. et al., 19764). Vitamin K deficiency has been implicated in several clinical ailments such as intracranial hemorrhage in newborn infants (Ferland, G. et al., 19935-Shearer, M. J., 19956) and possible bone fracture resulting from osteoporosis (Knapen, M. H. et al., 19897).
Vitamin K occurs naturally in two forms, namely, K1 (phylloquinone) in green plants and K2 (menaquinones-MK) in animals and some bacteria (Collins, M. D. et al., 19818-Conly, J. M. et al. 19929-Ramotar, K. et al., 198410-Taber, H. 198011-Watanuki, M. et al. 197212), including intestinal bacteria. MK has a variable side chain length of 4-13 isoprene units. They are referred to as MK−η, where η denotes the number of isoprenoid residues. The MK are constituents of the bacterial plasma membrane and function as redox reagents in electron transport and oxidative phosphorylation systems (Taber, H. 1980-Ramotar, K. et al. 1984).
Lactic acid bacteria have been used as starter cultures to manufacture various foods and can be generally recognized as safe (GRAS), and a qualitative study has shown that some lactic acid bacteria produce MK. In many countries, the daily requirement for vitamin K is around 1 μg/kg of body weight.
Rowland, B. M. and Taber, H. W. (1996)13-Rowland, B. et al. (1995)14-Taber H. W. et al. (1981)15 have extensively studied the mechanism of MK formation in Bacillus subtilis. However, studies to increase production of MK by B. subtilis have not been reported. Tani, Y. and Sakurai, N. (1987)16-Tani, Y. and Taniguchi, H. (1989)17 reported on the efficient production of MK-4, MK-5 and MK-6 by Flavobacterium and that the maximum concentration of MK produced reached 192 mg/l (Tani, Y. et al.-1989). On the other hand, industrial production of MKs with longer isoprene side chains was not reported until recently by Morishita, T. et al. (1999)18. In their study, 29-123 μg/l of MK-7 was produced by lactic acid bacteria. The fermented soybean “natto”, whose production requires B. subtilis, is popular in Japan and contains an exceptionally large amount of MK (600-900 μg/100 g) (Sakano, T. et al. 1988)19. Since the strains of B. subtilis used for manufacturing natto are edible, they are among the most advantageous source of MK in the food industry.
Yoshinori Tsukamoto et al. (2001) have recovered a analogous resistant mutant of B. subtilis “natto” having productivity of 1719 μg/100 g dry weight. According to a number of patents or patent applications exist, some of which are listed in the following, K2 (MK-7) is produced in amounts of 1.0 μg/g dry weight or below (US 2004/043015; US 2005/0025759; US 2002/0146786; US 2001/0046697).
It has now been found, and this is the object of the present invention, a Bacillus subtilis mutated strain having productivity ranging from 1,000 to 25,000 ppm of dry matter, with a production cycle (from pre-seed to fermentation) of 160-200 hours, more precisely 170-185 hours. The Bacillus subtilis mutant GN13/72 was obtained by treatments with NTG or, alternatively, U.V. and recovered on a micronised soy meal solid medium.
The strain was deposited under the terms of the Budapest Treaty at the Deutsche Sammiung von Mikroorganismen und Zellkulturen GmbH (DSMZ), located at Mascheroder Weg 1b. D-35124 Braunschweig, Germany, on Dec. 5, 2005 under the accession number DSM 17766.
The MK-7 high-content biomass is prepared according to known fermentation techniques by means of culture media containing carbon sources (such as glucose, saccharose, glycerol, starch hydrolysate and the like); nitrogen sources (such as yeast extract or autolysate, peptones of various origin, soy meal and the like); various salts (such as potassium phosphate, sodium chloride, magnesium sulfate, manganese sulfate, zinc sulfate, and the like).
pH ranges from 6.0 to 8.5, more precisely from 6.5 to 7.8; air flow ranges from 0.1 to 2.0 vvm, more precisely from 0.2.5 to 1.0 vvm; stirring rate in the fermenter varies from 100 to 250 rpm; pressure ranges between 0.1 and 1.2 bars, more precisely between 0.25 and 1.0 bars. Fermentation is carried out in batch or fed-batch mode; conventional STR (=Stirred Tank Reactor) or CSTR (=Continuous Stirred Tank Reactor) fermenters are used.
The biomass is collected by centrifugation or microfiltration, washed twice with purified water and resuspended in purified water. The resulting creams are dried by freeze-drying or spray-drying, then packaged under vacuum.
The invention is illustrated in detail by the following examples.
Bacillus subtilis GN13/72-DSM 17766 is aerobically grown in a 30 I (geometrical) fermenter containing 20 I of “F10” fermentation medium having the following composition:
The fermenter is inoculated with 8% (1600 ml) of 16 h (±2 h) seed, whose “S3” medium has the following composition:
The seed was in turn inoculated with 5 ml of B. subtilis suspension from a slant washed with 10 ml of purified water.
The biomass obtained under said conditions was 8 (±1) g/l dry weight with MK-7 content of 1100 (±100) ppm.
Bacillus subtilis GN13/72-DSM 17766 is cultured as in Example 1, the “F12” fermentation medium having the following composition:
10 (±1 g) g/l dry weight are obtained with MK-7 content of 3000 (±100) ppm.
Bacillus subtilis GN13/72-DSM 17766 is cultured as in Example 1, the “F13” fermentation medium having the following composition:
9.0 (±1.0) g/l dry weight are obtained with MK-7 content of 7800 (±200) ppm.
Bacillus subtilis GN13/72-DSM 17766 is cultured as in Example 3, the carbon source consisting of maltodextrin instead dextrin.
Duration of the fermentation 140 h (±3 h).
8.0 (±1.0) g/l dry weight are obtained with MK-7 content of 8500 (±150) ppm.
Bacillus subtilis GN13/72-DSM 17766 is cultured as in Example 4, the antifoam agent being soybean oil.
Duration of the fermentation 144 h (±4 h).
11 (±1) g/l dry weight are obtained with MK-7 content of 11700 (±300) ppm.
Bacillus subtilis GN13/72-DSM 17766 is cultured in a 300 l fermenter, with 225 l useful volume, medium “F13”, pH automatically kept at 7.2 (±0.1) with NaOH; stirring 100 rpm; air 0.5 vvm; pressure 0.3 bar; antifoam soybean oil automatically controlled.
Inoculum was 4% obtained in a seed of 30 l total with 20 l useful volume and “S3” medium (see Example 1).
Duration of the fermentation 142 h (±4 h). Obtained biomass 11 (±1.0) g/l dry weight Obtained MK-7: 15150 (±200) ppm.
Bacillus subtilis GN13/72-DSM 17766 is cultured as in Example 6. Fermentation was arrested before reaching the stationary phase. 7.0 (±1.5) g/l dry weight are obtained, with MK-7 productivity=21000 ppm. The biomass was divided into 2 parts: a part was freeze-dried to obtain a powder having 17000 (±350) ppm; the other part was spray-dried to obtain 20000 (±500) ppm.
Operative conditions of the Spray Dryer:
The procedure of Example 7 is followed, in which the fermentation useful volume was 2 m3. The spray-dried final product was packaged in 250 g sachets under vacuum.
| Number | Date | Country | Kind |
|---|---|---|---|
| 05425932 | Dec 2005 | EP | regional |
| Number | Name | Date | Kind |
|---|---|---|---|
| 3725200 | Watanabe et al. | Apr 1973 | A |
| 5024937 | Penticoff et al. | Jun 1991 | A |
| 5685128 | Chum et al. | Nov 1997 | A |
| 6677141 | Sumi | Jan 2004 | B2 |
| Number | Date | Country |
|---|---|---|
| 0 320 685 | Jun 1989 | EP |
| 3272657 | Dec 1991 | JP |
| Number | Date | Country | |
|---|---|---|---|
| 20070154998 A1 | Jul 2007 | US |
